DE10155900A1 - Cosmetic or dermatological spherical powders or gels for UV protection containing siloxane elastomers also contain inorganic micropigments and a bisresorcinyl triazine derivative - Google Patents

Abstract

Cosmetic and/or dermatological spherical powders or gels for use in UV protection and containing certain siloxane elastomers also contain inorganic micropigments and a bisresorcinyl triazine derivative. Cosmetic and/or dermatological spherical powders or gels for use in UV protection comprise: (a) a bisresorcinyl triazine derivative of formula (I); (b) inorganic micropigments; and (c) siloxane elastomers obtained by reaction of (i) inyl-terminated polymethylsiloxanes and methylhydrodimenthylsiloxanes or (ii) OH-terminated dimethylpolysiloxanes and trimethylsiloxy-terminated methylpolysiloxanes. R<1> - R<3> = 1-10C alkyl or H

Description

The present invention relates to cosmetic and / or dermatological Light protection formulations which have a particularly advantageous sensor system. simultaneously the formulation works synergistically with regard to the sun protection factors achieved. The Formulations are suitable for protecting the skin and / or hair from UV radiation and are applied to the skin or hair.

The harmful effect of the ultraviolet part of solar radiation on the skin is well known. Depending on their respective wavelength, the rays have different effects on the organ skin: the so-called UV-C radiation with a Wavelength that is less than 290 nm is from the ozone layer in the earth's atmosphere absorbed and therefore has no physiological meaning. In contrast, rays in the Range between 290 nm and 320 nm, the so-called UV-B range, an erythema, a simple sunburn or even more or less severe burns. As a The narrower range around 308 nm becomes the maximum of the erythema effectiveness of sunlight specified.

To protect against UV-B radiation, numerous compounds are known in which it are, for example, derivatives of 3-benzylidene camphor, 4-aminobenzoic acid, the Cinnamic acid, salicylic acid and benzophenone.

It has long been erroneously assumed that the long-wave UV-A radiation with a wavelength between 320 nm and 400 nm is only a negligible biological Has effect. However, numerous studies have now shown that UV-A Radiation with a view to triggering photodynamic, especially phototoxic Reactions and chronic changes in the skin are far more dangerous than UV-B radiation. The damaging influence of UV-B radiation can also still be caused by UV-A radiation be reinforced.

So it is u. a. proved that even the UV-A radiation under normal Everyday conditions are sufficient to damage the collagen and elastin fibers within a short time, which are essential for the structure and firmness of the skin. hereby there are chronic light-related skin changes - the skin "ages" prematurely. The clinical appearance of light-aged skin includes, for example Wrinkles and fine lines as well as an irregular, furrowed relief. Furthermore, those of Areas affected by light-induced skin aging have irregular pigmentation exhibit. The formation of brown spots, keratoses and even carcinomas or malignant melanoma is possible. Skin prematurely aged due to everyday UV exposure is also characterized by a lower activity of the Langerhans cells and a mild, chronic inflammation.

About 90% of the ultraviolet radiation reaching the earth consists of UV-A rays. While UV-B radiation varies greatly depending on numerous factors (e.g. Time of year and day or latitude), the UV-A radiation remains independent of annual and daytime or geographic factors relatively constant day by day. simultaneously the majority of UV-A radiation penetrates into the living epidermis while about 70% of the UV-B rays are retained by the horny layer.

It is therefore of fundamental importance that cosmetic and dermatological Sufficient sunscreen preparations against both UV-B and UV-A radiation Provide protection.

Inorganic micropigments are also suitable as light stabilizers. These act in such a way that they reflect the UVA and UV-B rays on the skin surface. The particle sizes of the pigments are chosen so that the individual particles are no longer perceptible to the eye. For example, pigments based on metal oxides and / or other metal compounds which are sparingly soluble or insoluble in water are used, in particular the oxides of titanium (TiO ₂ ), zinc (ZnO), iron (e.g. Fe ₂ O ₃ ), zirconium (ZrO ₂ ), Silicon (SiO ₂ ), manganese (e.g. MnO), aluminum (Al ₂ O ₃ ), cerium (e.g. Ce ₂ O ₃ ), mixed oxides of the corresponding metals, mixtures of such oxides and the sulfate of Bariums (BaSO ₄ ). The inorganic pigments are often used in hydrophobic form, ie they are treated to be water-repellent on the surface. This surface treatment can consist in that the pigments are provided with a thin hydrophobic layer by methods known per se.

The use of solid elastomeric polyorganosiloxanes or organopolysiloxanes, hereinafter referred to as siloxane elastomers, in cosmetic preparations is known per se and has become increasingly important in recent years. In addition to their use in cosmetics, these substances were used in food and feed, pharmaceuticals, impregnating agents, lubricants and so on. Siloxal elastomers are partially or completely cross-linked and mostly have a three-dimensional structure. They can be obtained by a reaction of vinyl-terminated polymethylsiloxane and methylhydrodimenthylsiloxane


or also by reaction of hydroxy-terminated dimethylpolysiloxane and trimethylsiloxy-terminated methylpolysiloxane:

These siloxane elastomers are used, for example, to adjust the rheological Properties of a preparation used. Such are described Siloxane elastomers, for example in European Patent 295886 and U.S. Patent 5,266,321, which discloses the use of these substances in facial cleansers or oily makeup products. In these writings there is also Nature of the siloxane elastomers described in more detail. The siloxane elastomers are used in cosmetic preparations in particular due to their pleasant sensory Properties, the resulting products are considered velvety, powdery and / or matting described. They also have stabilizing effects on formulations with a high oil content with low water contents of at most 5% by weight. When formulating the above mentioned products often poses the problem that the siloxane elastomers with others frequently used components are incompatible, which leads to unsatisfactory Long-term stability of the products leads.

The object of the present invention was cosmetic and / or dermatological To provide sunscreen preparations which have the disadvantages of the prior art Do not have technology and especially high sun protection factors, good Long-term storage stability, pleasant sensory properties and improved Have water resistance.

It has not been foreseen by the person skilled in the art that cosmetic and / or dermatological preparation for protection against UV radiation with bis-resorcinyltriazine derivatives is characterized by the following structure:


where R ¹ , R ² and R ^{3 are} independently selected from the group of branched and unbranched alkyl groups having 1 to 10 carbon atoms or a single hydrogen atom, inorganic micropigments and at least one siloxane elastomer selected from the group of siloxane elastomers obtainable either by reaction of Remedy the shortcomings of the prior art in the form of spherical powder or in the form of gels by vinyl-terminal polymethylsiloxane and methylhydrodimenthylsiloxane or by reaction of hydroxy-terminal dimethylpolysiloxane and trimethylsiloxy-terminal methylpolysiloxane. It is preferred if siloxane elastomers selected from the groups of siloxane elastomers,
(a) the units R ₂ SiO and RSiO _1.5 and / or R ₃ SiO _0.5 and / or SiO ₂ contain, the individual radicals R each independently of one another hydrogen, alkyl such as methyl, ethyl, propyl or aryl such as for example phenyl or tolyl, alkenyl such as vinyl and the weight ratio of the units R ₂ SiO to RSiO _{1.5 is selected} in the range from 1: 1 to 30: 1;
(b) which are insoluble and swellable in silicone oil, which can be obtained by the addition reaction of an organopolysiloxane (1) which contains silicon-bonded hydrogen with an organopolysiloxane (2) which contains unsaturated aliphatic groups, the proportions used being chosen so that the amount of hydrogen of the organopolysiloxane (1) or the unsaturated aliphatic groups of the organopolysiloxane (2) is in the range of 1 to 20 mol% if the organopolysiloxane is not cyclic and in the range of 1 to 50 mol% if that Organopolysiloxane is cyclic can be used. It is particularly preferred if the organopolysiloxane elastomer is used in combination with oils from hydrocarbons of animal and / or vegetable origin, synthetic oils, synthetic esters, synthetic ethers or mixtures thereof. It is very particularly preferred if the organopolysiloxane elastomer is used in combination with unbranched silicone oils which are liquid or pasty at room temperature or cyclic silicone oils or mixtures thereof. It is very exceptionally preferred if the organopolysiloxane elastomer is used in the form of a gel composed of organopolysiloxane elastomer and a lipid phase, the content of the organopolysiloxane elastomer in the gel being 3 to 80% by weight, very particularly preferably 0.3 to 60% by weight. is.

Furthermore, it is preferred if the inorganic micropigment contains metal oxides with a average particle size of 10 to 60 nm can be used. It is particularly preferred if as inorganic micropigments oxides of titanium, iron, zinc, zirconium or of the cer can be used. It is very particularly preferred if as inorganic Micropigments coated metal oxides are used. It is preferred if the inorganic micropigments are present in a proportion of 0.5 to 30% by weight.

It is further preferred if the 2,4-bis - {[4- (2- Ethyl-hexyloxy) -2-hydroxy] phenyl) -6- (4-methoxyphenyl) -1,3,5-triazine (INCI: Aniso triazine), which is sold under the trade name Tinosorb® S by CIBA-Chemicals GmbH is available is used. It is particularly preferred if the content of one or several bis-resorcinyltriazine derivatives in the range 0.1 to 20% by weight, advantageously 0.1 up to 15% by weight, very particularly preferably 0.1 to 10% by weight.

Furthermore, it is preferred if the preparations have at least one further UV Filter substance selected from the group of triazines, hydroxyaminobenzophenones, which in Room temperature liquid UV filter, sulfonated, water-soluble UV filter, oil-soluble UV Broadband filters and organic and / or inorganic pigments, which are preferably superficial are treated. The preparations according to the invention are preferred for Protection of the skin or hair against UV light, damage caused by UV light and through Signs of aging caused by UV light are used.

• - ungewöhnliche sensorische Eigenschaften aufweisen, indem sie geschmeidig und dabei reichhaltig wirken, aber dennoch keinen fettigen Rückstand auf der Haut hinterlassen,
• - gegenüber für O/W-Emulsionen charakteristischer Haptik eine vorteilhafte Konsistenzverbesserung aufweisen,
• - eine synergistische Erhöhung der Lichtschutzwirkung zeigen,
• - erhöhte UV-A-Filterwirkung haben,
• - eine höhere Wasserfestigkeit bieten,
• - besser der Hautaustrocknung entgegenwirken, als die Zubereitungen des Standes der Technik.

The preparations according to the invention are extremely satisfactory preparations in every respect. It was not foreseeable for the person skilled in the art that the preparations according to the invention

• - have unusual sensory properties in that they appear supple and rich, but still leave no greasy residue on the skin,
• have an advantageous improvement in consistency compared to the haptics characteristic of O / W emulsions,
• - show a synergistic increase in the light protection effect,
• - have an increased UV-A filter effect,
• - offer higher water resistance,
• - counteract the drying out of the skin better than the preparations of the prior art.

• - von lichtbedingten Hautschäden
• - von entzündlichen Hautzuständen sowie atopischem Ekzem, seborrhoischem Ekzem, polymorpher Lichtdermatose, Psoriasis, Vitiligo

möglich. When using the preparations according to the invention is surprisingly an effective treatment, but also a prophylaxis

• - from light-related skin damage
• - of inflammatory skin conditions as well as atopic eczema, seborrheic eczema, polymorphic light dermatosis, psoriasis, vitiligo

possible.

It is advantageous to use siloxane elastomers in the formulations according to the invention Dow Corning, as described in U.S. Patent 5654362 described and available under the trade name 9040 Silicone Elastomer Blend are to be used. Grant's siloxane elastomers are also advantageous Chemical with the INCI name Polysilicone-11 such as the types Gransil GCM or Gransil PM, as described in US Pat. Nos. 5266321, 4980167 and 4742142 are described. Particularly advantageous siloxane elastomers are still those in the form of spherical powders with an average particle size of 2 up to 5 µm and a particle size distribution of 1 to 15 µm and in the Japanese patents 4-66446 and 4-17162 and Japanese Patent Application Laid-Open 2-243612 or with an average Particle size of less than 50 microns in the documents EP 0295 886 and US 4761454 are described. Commercially available products are, for example, Torayfil E-505C, Torayfil E-506 C from Toray-Dow Corning Silicone Co.

A particularly advantageous siloxane elastomer in the form of spherical powder is Dimethicone / Vinyldimethicone Crosspolymer with a particle size distribution from 1 to 15 µm, available under the trade name Dow Corning 9506 Powder from Dow Corning. Also advantageous are the gels containing siloxane elastomers, which are listed below trade names KSG-15, -16, -17, -18, -20 from Shin-Etsu or Gransil 5CYCgel, Gransil SR DMF 10gel, Gransil SR DC 556gel from the company Grant Chemical, SF 839, SF1204, JK113 from General Electric and Lauryl Dimeticon / vinyldimethicone crosspolymers as they are known under the names KSG41, -42, -43, -44 are available from Shin-Etsu. Another beneficial one Siloxane elastomer is the cyclomethicone + vinyl dimethicone / methicon cross polymer or the chemically related elastomer Crosslinked Stearyl Methyl Dimethyl Siloxane Elastomer, as for example from the company Grant Chemical under the Designation SR-CYC can be offered.

Preparations according to the invention which are present as emulsions contain one or several emulsifiers. These emulsifiers can advantageously be chosen from the Group of nonionic, anionic, cationic or amphoteric emulsifiers.

• a) Partialfettsäureester und Fettsäureester mehrwertiger Alkohole und deren ethoxylierte Derivate (z. B. Glycerylmonostearate, Sorbitanstearate, Glycerylstearylcitrate, Sucrosestearate)
• b) ethoxilierte Fettalkohole und Fettsäuren
• c) ethoxilierte Fettamine, Fettsäureamide, Fettsäurealkanolamide
• d) Alkylphenolpolyglycolether (z. B. Triton X)

Among the nonionic emulsifiers are

• a) Partial fatty acid esters and fatty acid esters of polyhydric alcohols and their ethoxylated derivatives (e.g. glyceryl monostearates, sorbitan stearates, glyceryl stearyl citrates, sucrose stearates)
• b) ethoxylated fatty alcohols and fatty acids
• c) ethoxylated fatty amines, fatty acid amides, fatty acid alkanolamides
• d) alkylphenol polyglycol ether (e.g. Triton X)

• a) Seifen (z. B. Natriumstearat)
• b) Fettalkoholsulfate
• c) Mono-, Di- und Trialkylphosphosäureester und deren Ethoxylate

Among the anionic emulsifiers are

• a) soaps (e.g. sodium stearate)
• b) fatty alcohol sulfates
• c) mono-, di- and trialkylphosphonic acid esters and their ethoxylates

• a) quaternäre Ammoniumverbindungen mit einem langkettigen aliphatischen Rest z. B. Distearyldimonium Chloride

Among the cationic emulsifiers are

• a) quaternary ammonium compounds with a long-chain aliphatic radical z. B. Distearyldimonium Chloride

• a) Alkylamininoalkancarbonsäuren
• b) Betaine, Sulfobetaine
• c) Imidazolinderivate

Among the amphoteric emulsifiers are

• a) Alkylamininoalkane carboxylic acids
• b) betaines, sulfobetaines
• c) Imidazoline derivatives

There are also naturally occurring emulsifiers, including beeswax, Wool wax, lecithin and sterols belong to it.

• - der Fettalkoholethoxylate
• - der ethoxylierten Wollwachsalkohole,
• - der Polyethylenglycolether der allgemeinen Formel
  
  R-O-(-CH₂-CH₂-O-)_n-R',
  
• - der Fettsäureethoxylate der allgemeinen Formel
  
  R-COO-(-CH₂-CH₂-O-)_n-H,
  
• - der veretherten Fettsäureethoxylate der allgemeinen Formel
  R-COO-(-CH₂-CH₂-O-)_n-R',
  
• - der veresterten Fettsäureethoxylate der allgemeinen Formel
  
  R-COO-(-CH₂CH₂O)_n-C(O)-R',
  
• - der Polyethylenglycolglycerinfettsäureester
• - der ethoxylierten Sorbitanester
• - der Cholesterinethoxylate
• - der ethoxylierten Triglyceride
• - der Alkylethercarbonsäuren der allgemeinen Formel
  
  R-O-(-CH₂CH₂O-)_n-CH₂-COOH und n eine Zahl von 5 bis 30 darstellen,
  
• - der Polyoxyethylensorbitolfettsäureester,
• - der Alkylethersulfate der allgemeinen Formel
  
  R-O-(-CH₂-CH₂-O-)_n-SO₃-H
  
• - der Fettalkoholpropoxylate der allgemeinen Formel
  
  R-O-(-CH₂CH(CH₃)-O-)_n-H,
  
• - der Polypropylenglycolether der allgemeinen Formel
  
  R-O-(-CH₂-CH(CH₃)-O-)_n-R',
  
• - der propoxylierten Wollwachsalkohole,
• - der veretherten Fettsäurepropoxylate
  
  R-COO-(-CH₂-CH(CH₃)-O-)_n-R',
  
• - der veresterten Fettsäurepropoxylate der allgemeinen Formel
  
  R-COO-(-CH₂-CH(CH₃)-O-)_n-C(O)-R',
  
• - der Fettsäurepropoxylate der allgemeinen Formel
  
  R-COO-(-CH₂-CH(CH₃)-O-)_n-H,
  
• - der Polypropylenglycolglycerinfettsäureester
• - der propoxylierten Sorbitanester
• - der Cholesterinpropoxylate
• - der propoxylierten Triglyceride
• - der Alkylethercarbonsäuren der allgemeinen Formel
  
  R-O-(-CH₂-CH(CH₃)O-)_n-CH₂-COOH
  
• - der Alkylethersulfate bzw. die diesen Sulfaten zugrundeliegenden Säuren der allgemeinen Formel
  
  R-O-(-CH₂-CH(CH₃)-O-)_n-SO₃-H
  
• - der Fettalkoholethoxylate/propoxylate der allgemeinen Formel
  
  R-O-X_n-Y_m-H,
  
• - der Polypropylenglycolether der allgemeinen Formel
  
  R-O-X_n-X_m-R',
  
• - der veretherten Fettsäurepropoxylate der allgemeinen Formel
  
  R-COO-X_n-Y_m-R',
  
• - der Fettsäureethoxylate/propoxylate der allgemeinen Formel
  
  R-COO-X_nX_m-H.

O / W emulsifiers can, for example, advantageously be selected from the group of polyethoxylated or polypropoxylated or polyethoxylated and polypropoxylated products, e.g. B .:

• - The fatty alcohol ethoxylates
• - the ethoxylated wool wax alcohols,
• - The polyethylene glycol ether of the general formula
  
  RO - (- CH ₂ -CH ₂ -O-) _n -R ',
  
• - The fatty acid ethoxylates of the general formula
  
  R-COO - (- CH ₂ -CH ₂ -O-) _n -H,
  
• - The etherified fatty acid ethoxylates of the general formula
  R-COO - (- CH ₂ -CH ₂ -O-) _n -R ',
  
• - The esterified fatty acid ethoxylates of the general formula
  
  R-COO - (- CH ₂ CH ₂ O) _n -C (O) -R ',
  
• - The polyethylene glycol glycerol fatty acid ester
• - The ethoxylated sorbitan esters
• - the cholesterol ethoxylates
• - The ethoxylated triglycerides
• - The alkyl ether carboxylic acids of the general formula
  
  RO - (- CH ₂ CH ₂ O-) _n -CH ₂ -COOH and n represent a number from 5 to 30,
  
• - the polyoxyethylene sorbitol fatty acid ester,
• - The alkyl ether sulfates of the general formula
  
  RO - (- CH ₂ -CH ₂ -O-) _n -SO ₃ -H
  
• - The fatty alcohol propoxylates of the general formula
  
  RO - (- CH ₂ CH (CH ₃ ) -O-) _n -H,
  
• - The polypropylene glycol ether of the general formula
  
  RO - (- CH ₂ -CH (CH ₃ ) -O-) _n -R ',
  
• - the propoxylated wool wax alcohols,
• - The etherified fatty acid propoxylates
  
  R-COO - (- CH ₂ -CH (CH ₃ ) -O-) _n -R ',
  
• - The esterified fatty acid propoxylates of the general formula
  
  R-COO - (- CH ₂ -CH (CH ₃ ) -O-) _n -C (O) -R ',
  
• - The fatty acid propoxylates of the general formula
  
  R-COO - (- CH ₂ -CH (CH ₃ ) -O-) _n -H,
  
• - the polypropylene glycol glycerol fatty acid ester
• - The propoxylated sorbitan esters
• - the cholesterol propoxylates
• - the propoxylated triglycerides
• - The alkyl ether carboxylic acids of the general formula
  
  RO - (- CH ₂ -CH (CH ₃ ) O-) _n -CH ₂ -COOH
  
• - The alkyl ether sulfates or the acids of the general formula on which these sulfates are based
  
  RO - (- CH ₂ -CH (CH ₃ ) -O-) _n -SO ₃ -H
  
• - The fatty alcohol ethoxylates / propoxylates of the general formula
  
  ROX _n -Y _m -H,
  
• - The polypropylene glycol ether of the general formula
  
  ROX _n -X _m -R ',
  
• - The etherified fatty acid propoxylates of the general formula
  
  R-COO-X _n -Y _m -R ',
  
• - The fatty acid ethoxylates / propoxylates of the general formula
  
  R-COO-X _n X _m -H.

According to the invention, the polyethoxylated or polypropoxylated or polyethoxylated and polypropoxylated O / W emulsifiers chosen from the group of substances with HLB values of 11-18, especially advantageous with HLB values of 14.5-15.5, provided the O / W emulsifiers are saturated residues R and R 'have. If the O / W emulsifiers have unsaturated radicals R and / or R ', or if there are isoalkyl derivatives, the preferred HLB value of such emulsifiers can be are also lower or higher.

It is advantageous to choose the fatty alcohol ethoxylates from the group of the ethoxylated stearyl alcohols, cetyl alcohols, cetylstearyl alcohols (cetearyl alcohols). The following are particularly preferred:
Polyethylene glycol (13) stearyl ether (steareth-13), polyethylene glycol (14) stearyl ether (steareth-14), polyethylene glycol (15) stearyl ether (steareth-15), polyethylene glycol (16) stearyl ether (steareth-16), polyethylene glycol (17) stearyl ether ( Steareth-17), polyethylene glycol (18) stearyl ether (Steareth-18), polyethylene glycol (19) stearyl ether (Steareth-19), polyethylene glycol (20) stearyl ether (Steareth-20),
Polyethylene glycol (12) isostearyl ether (isosteareth-12), polyethylene glycol (13) isostearyl ether (isosteareth-13), polyethylene glycol (14) isostearyl ether (isosteareth-14), polyethylene glycol (15) isostearyl ether (isosteareth-15), polyethylene glycol (16) isostearyl ether ( Isosteareth-16), polyethylene glycol (17) isostearyl ether (isosteareth-17), polyethylene glycol (18) isostearyl ether (isosteareth-18), polyethylene glycol (19) isostearyl ether (isisteareth-19), polyethylene glycol (20) isostearyl ether (isosteareth-20),
Polyethylene glycol (13) cetyl ether (ceteth-13), polyethylene glycol (14) cetyl ether (ceteth-14), polyethylene glycol (15) cetyl ether (ceteth-15), polyethylene glycol (16) cetyl ether (ceteth-16), polyethylene glycol (17) cetyl ether ( Ceteth-17), polyethylene glycol (18) cetyl ether (ceteth-18), polyethylene glycol (19) cetyl ether (ceteth-19), polyethylene glycol (20) cetyl ether (ceteth-20),
Polyethylene glycol (13) isocetyl ether (isoceteth-13), polyethylene glycol (14) isocetyl ether (isoceteth-14), polyethylene glycol (15) isocetyl ether (isoceteth-15), polyethylene glycol (16) - isocetyl ether (isoceteth-16), polyethylene glycol (17) isocetyl ether (Isoceteth-17), polyethylene glycol (18) isocetyl ether (isoceteth-18), polyethylene glycol (19) isocetyl ether (isoceteth-19), polyethylene glycol (20) isocetyl ether (isoceteth-20),
Polyethylene glycol (12) oleyl ether (oleth-12), polyethylene glycol (13) oleyl ether (oleth-13), polyethylene glycol (14) oleyl ether (oleth-14), polyethylene glycol (15) oleyl ether (oleth-15),
Polyethylene glycol (12) lauryl ether (Laureth-12), polyethylene glycol (12) isolauryl ether (Isolaureth-12).
Polyethylene glycol (13) cetyl stearyl ether (ceteareth-13), polyethylene glycol (14) cetyl stearyl ether (ceteareth-14), polyethylene glycol (15) cetyl stearyl ether (ceteareth-15), polyethylene glycol (16) cetyl stearyl ether (ceteareth-16), polyethylene glycol (17) Ceteareth-17), polyethylene glycol (18) cetylstearyl ether (ceteareth-18), polyethylene glycol (19) cetylstearyl ether (ceteareth-19), polyethylene glycol (20) cetylstearyl ether (ceteareth-20),

It is also advantageous to choose the fatty acid ethoxylates from the following group:
Polyethylene glycol (20) stearate, polyethylene glycol (21) stearate, polyethylene glycol (22) stearate, polyethylene glycol (23) stearate, polyethylene glycol (24) stearate, polyethylene glycol (25) stearate,
Polyethylene glycol (12) isostearate, polyethylene glycol (13) isostearate, polyethylene glycol (14) isostearate, polyethylene glycol (15) isostearate, polyethylene glycol (16) isostearate, polyethylene glycol (17) isostearate, polyethylene glycol (18) isostearate, polyethylene glycol (19) isostearate (20) isostearate, polyethylene glycol (21) isostearate, polyethylene glycol (22) isostearate, polyethylene glycol (23) isostearate, polyethylene glycol (24) isostearate, polyethylene glycol (25) isostearate,
Polyethylene glycol (12) oleate, Polyethylene glycol (13) oleate, Polyethylene glycol (14) oleate, Polyethylene glycol (15) oleate, Polyethylene glycol (16) oleate, Polyethylene glycol (17) oleate, Polyethylene glycol (18) oleate, Polyethylene glycol (19) oleate, Polyethylene glycol ( 20) oleate

As an ethoxylated alkyl ether carboxylic acid or its salt, this can be advantageous Sodium laureth-11 carboxylate can be used.

Sodium laureth 1-4 sulfate can advantageously be used as alkyl ether sulfate.

As an ethoxylated cholesterol derivative can be advantageous Polyethylene glycol (30) cholesteryl ether can be used. Polyethylene glycol (25) soyasterol has also proven itself.

Polyethylene glycol (60) evening can advantageously be used as ethoxylated triglycerides Primrose Glycerides can be used (Evening Primrose = evening primrose)

Another advantage is the polyethylene glycol glycerol fatty acid ester from the group Polyethylene glycol (20) glyceryl laurate, polyethylene glycol (21) glyceryl laurate, polyethylene glycol (22) glyceryl laurate, polyethylene glycol (23) glyceryl laurate, Polyethylene glycol (6) glyceryl caprate / caprinate, polyethylene glycol (20) glyceryl oleate, Polyethylene glycol (20) glyceryl isostearate, polyethylene glycol (18) glyceryl oleate / cocoat to choose.

It is also cheap to use the sorbitan esters from the group Polyethylene glycol (20) sorbitan monolaurate, polyethylene glycol (20) sorbitan monostearate, Polyethylene glycol (20) sorbitan monoisostearate, polyethylene glycol (20) sorbitan monopalmitate, polyethylene glycol (20) - to choose sorbitan monooleate.

Advantageous W / O emulsifiers that can be used are: fatty alcohols with 8 to 30 Carbon atoms, monoglycerol esters saturated and / or unsaturated, branched and / or unbranched alkane carboxylic acids with a chain length of 8 to 24, in particular 12-18 carbon atoms, diglycerol esters saturated and / or unsaturated, branched and / or unbranched alkane carboxylic acids with a chain length of 8 to 24, in particular 12-18 carbon atoms, monoglycerol ethers saturated and / or unsaturated, branched and / or unbranched alcohols with a chain length of 8 to 24, in particular 12-18 C- Atoms, diglycerol ethers saturated and / or unsaturated, branched and / or unbranched alcohols with a chain length of 8 to 24, in particular 12-18, carbon atoms, Propylene glycol esters saturated and / or unsaturated, branched and / or unbranched alkane carboxylic acids with a chain length of 8 to 24, in particular 12-18 C atoms and sorbitan esters saturated and / or unsaturated, branched and / or unbranched alkane carboxylic acids with a chain length of 8 to 24, in particular 12-18 C-atoms.

Particularly advantageous W / O emulsifiers are glyceryl monostearate, Glyceryl monoisostearate, glyceryl monomyristate, glyceryl monooleate, diglyceryl monostearate, Diglyceryl monoisostearate, propylene glycol monostearate, propylene glycol monoisostearate, Propylene glycol monocaprylate, propylene glycol monolaurate, sorbitan monoisostearate, Sorbitan monolaurate, sorbitan monocaprylate, sorbitan monoisooleate, sucrose distearate, Cetyl alcohol, stearyl alcohol, arachidyl alcohol, behenyl alcohol, isobehenyl alcohol, Selachyl alcohol, chimyl alcohol, polyethylene glycol (2) stearyl ether (Steareth-2), Glyceryl monolaurate, glyceryl monocaprinate, glyceryl monocaprylate.

Those cosmetic and dermatological preparations which are in the Form of a sunscreen. In addition to the Active ingredient combinations according to the invention additionally at least one UV-A filter substance and / or at least one UV-B filter substance and / or at least one inorganic pigment.

However, it is also advantageous in the sense of the present invention to use such cosmetic and to create dermatological preparations, the main purpose of which is not the Protection against sunlight is, but which nevertheless contains UV protection substances contain. So z. B. in day creams usually UV-A or UV-B filter substances incorporated.

UV protection substances, as well as antioxidants and, if desired, Preservatives, an effective protection of the preparations themselves against spoilage represents.

The preparations according to the invention advantageously contain the substances which Absorb UV radiation in the UV-A and / or UV-B range, in a total amount of e.g. B. 0.1% by weight to 30% by weight, preferably 0.5 to 20% by weight, in particular 1.0 to 15.0% by weight, based in each case on the total weight of the preparations, for cosmetic To provide preparations that cover the hair or skin before the whole Protect the area of ultraviolet radiation. You can also use it as a sunscreen Serve hair or skin.

Accordingly, the preparations contain within the meaning of the present invention preferably at least one UV-A and / or UV-B filter substance. The wording can, although not necessary, optionally one or more organic and / or contain inorganic pigments as UV filter substances, which in the water and / or can be present in the oil phase.

Preferred inorganic pigments are metal oxides and / or other metal compounds which are sparingly soluble or insoluble in water, in particular oxides of titanium (TiO ₂ ), zinc (ZnO), iron (e.g. Fe ₂ O ₃ ), zirconium (ZrO ₂ ), silicon ( SiO ₂ ), manganese (e.g. MnO), aluminum (Al ₂ O ₃ ), cerium (e.g. Ce ₂ O ₃ ), mixed oxides of the corresponding metals and mixtures of such oxides, as well as the sulfate of barium (BaSO ₄ ).

The titanium dioxide pigments can be used in both the rutile and anatase crystal modifications are present and can advantageously be treated superficially within the meaning of the present invention ("coated"), being, for example, a hydrophilic, amphiphilic or hydrophobic Character should be formed or preserved. This surface treatment can be in it exist that the pigments according to known methods with a thin hydrophilic and / or hydrophobic inorganic and / or organic layer. The Various surface coatings can also be used for the purposes of the present invention Contain water.

Inorganic surface coatings in the sense of the present invention can consist of aluminum oxides (Al ₂ O ₃ ), aluminum hydroxides Al (OH) ₃ , sodium hexa metaphosphate (NaPO ₃ ) ₆ , sodium metaphosphate (NaPO ₃ ) _n , silicon dioxide (SiO ₂ ) (also: Silica, CAS no .: 7631-86-9), aluminum oxides (Al ₂ O ₃ ), aluminum hydroxides Al (OH) ₃ or aluminum oxide hydrate (also: alumina, CAS no .: 1333-84-2), or iron oxide (Fe ₂ O ₃ ). These inorganic surface coatings can occur alone, in combination and / or in combination with organic coating materials.

Organic surface coatings in the sense of the present invention can consist of vegetable or animal aluminum stearates, vegetable or animal Stearic acid, lauric acid, dimethylpolysiloxane (also: Dimethicone), methylpolysiloxane (Methicone), Simethicone (a mixture of Dimethylpolysiloxane with an average chain length of 200 to 350 dimethylsiloxane Units and silica gel) or alginic acid. These organic Surface coatings can be used alone, in combination and / or in combination with inorganic coating materials occur.

Coated and uncoated titanium dioxides described can be used in the sense of the present Invention also in the form of commercially available oily or aqueous predispersions for Application come. These predispersions can advantageously be used as dispersants and / or solubilizing agents may be added.

Suitable titanium dioxide particles and predispersions of titanium dioxide particles are available under the following trade names from the companies listed:

Zinc oxide particles and predispersions of zinc oxide particles suitable according to the invention are available under the following trade names from the listed companies:

An advantageous organic pigment for the purposes of the present invention is 2,2'-methylene-bis- (6- (2H-benzotriazol-2-yl) -4- (1,1,3,3-tetramethylbutyl) phenol) [INCI : Bisoctyltriazole], which is characterized by the chemical structural formula


and is available under the trade name Tinosorb® M from CIBA-Chemicals GmbH.

Preparations according to the invention advantageously contain substances which emit UV radiation Absorb UV-A and / or UV-B range, the total amount of filter substances z. B. 0.1 wt .-% to 30 wt .-%, preferably 0.5 to 20 wt .-%, in particular 1.0 to 15.0% by weight, based on the total weight of the preparations, is cosmetic To provide preparations that cover the hair or skin before the whole Protect the area of ultraviolet radiation. You can also use it as a sunscreen Serve hair or skin.

Advantageous UV-A filter substances in the sense of the present invention are Dibenzoylmethane derivatives, especially the 4- (tert-butyl) -4'-methoxydibenzoylmethane (CAS no. 70356-09-1), which is sold by Givaudan under the Parsol® 1789 brand and by Merck under the Trade name Eusolex® 9020 is sold.

Other advantageous UV-A filter substances are phenylene-1,4-bis (2-benzimidazyl) -3,3'- 5,5'-tetrasulfonic acid


and their salts, especially the corresponding sodium, potassium or triethanolammonium salts, in particular the phenylene-1,4-bis (2-benzimidazyl) -3,3'-5,5'-tetrasulfonic acid bisodium salt


with the INCI name bisimidazylate, which is available, for example, from Haarmann & Reimer under the trade name Neo Heliopan AP.

Also advantageous are the 1,4-di (2-oxo-10-sulfo-3-bornylidenemethyl) benzene and its salts (especially the corresponding 10-sulfato compounds, especially the corresponding sodium, potassium or triethanolammonium salt) , which is also called benzene-1,4-di (2-oxo-3-bornylidenemethyl-10-sulfonic acid) and is characterized by the following structure:

Further advantageous UV-A filters are hydroxybenzophenones, in particular aminobenzophenone, which has the chemical structural formula


is marked. This has the chemical name 2- (4 '- (Diethylamino) -2'-hydoxybenzoyl) -benzoic acid hexyl ester.

Advantageous UV filter substances in the sense of the present invention are furthermore so-called broadband filters, d. H. Filter substances that contain both UV-A and UV-B radiation absorb.

Particularly advantageous preparations in the sense of the present invention, which are characterized by high or very high UV-A protection, preferably contain several UV A and / or broadband filters, especially dibenzoylmethane derivatives [for example the 4- (tert-Butyl) -4'-methoxydibenzoylmethane], benzotriazole derivatives [for example that 2,2'-methylene-bis- (6- (2H-benzotriazol-2-yl) -4- (1,1,3,3-tetramethylbutyl) phenol)], phenylene-1,4-bis- (2-benzimidazyl) -3,3'-5,5'-tetrasulfonic acid and / or its salts, the 1,4-di (2-oxo-10-sulfo-3- bornylidenmethyl) -benzene and / or its salts and / or that 2,4-bis - ((4- (2-Ethylhexyloxy) -2-hydroxy] phenyl) -6- (4-methoxyphenyl) -1,3,5-triazine, individually or in any Combinations with each other.

Also other UV filter substances, which the structural motif


are advantageous UV filter substances for the purposes of the present invention, for example the s-triazine derivatives described in European patent application EP 570 838 A1, the chemical structure of which is given by the generic formula


is reproduced, whereby
R represents a branched or unbranched C ₁ -C ₁₈ alkyl radical, a C ₅ -C ₁₂ cycloalkyl radical, optionally substituted with one or more C ₁ -C ₄ alkyl groups,
X represents an oxygen atom or an NH group,
R _{1 is} a branched or unbranched C ₁ -C ₁₈ alkyl radical, a C ₅ -C ₁₂ cycloalkyl radical, optionally substituted with one or more C ₁ -C ₄ alkyl groups, or a hydrogen atom, an alkali metal atom, an ammonium group or a group of formula


means in which
A represents a branched or unbranched C ₁ -C ₁₈ alkyl radical, a C ₅ -C ₁₂ cycloalkyl or aryl radical, optionally substituted by one or more C ₁ -C ₄ alkyl groups,
R _{3 represents} a hydrogen atom or a methyl group,
n represents a number from 1 to 10,
R _{2 represents} a branched or unbranched C ₁ -C ₁₈ alkyl radical, a C ₅ -C ₁₂ cycloalkyl radical, optionally substituted with one or more C ₁ -C ₄ alkyl groups, when X represents the NH group, and
a branched or unbranched C ₁ -C ₁₈ alkyl radical, a C ₅ -C ₁₂ cycloalkyl radical, optionally substituted with one or more C ₁ -C ₄ alkyl groups, or a hydrogen atom, an alkali metal atom, an ammonium group or a group of the formula


means in which
A represents a branched or unbranched C ₁ -C ₁₈ alkyl radical, a C ₅ -C ₁₂ cycloalkyl or aryl radical, optionally substituted by one or more C ₁ -C ₄ alkyl groups,
R _{3 represents} a hydrogen atom or a methyl group,
n represents a number from 1 to 10,
when X represents an oxygen atom.

A particularly preferred UV filter substance in the sense of the present invention is also an asymmetrically substituted s-triazine, the chemical structure of which is represented by the formula


is reproduced, which is also referred to below as dioctylbutylamidotriazon (INCI: dioctylbutamidotriazone) and is available under the trade name UVASORB HEB from Sigma 3V.

A symmetrically substituted s- is also advantageous in the sense of the present invention. Triazine, the 4,4 ', 4 "- (1,3,5-triazine-2,4,6-triyltriimino) tris-benzoic acid tris (2-ethylhexyl ester), synonym: 2,4,6-tris- [anilino- (p-carbo-2'-ethyl-1'-hexyloxy)] - 1,3,5-triazine (INCI: octyl Triazone), which is sold by BASF Aktiengesellschaft under the trade name UVINUL® T 150 is distributed.

The European Offenlegungsschrift 775 698 also describes bis-resorcinyltriazine derivatives which are preferably to be used, the chemical structure of which is given by the generic formula


is reproduced, wherein R ₁ , R ₂ and A _{1 represent a} wide variety of organic radicals.

Also advantageous in the sense of the present invention are the 2,4-bis - {[4- (3-sulfonato) -2- hydroxypropyloxy) -2-hydroxy] phenyl} -6- (4-methoxyphenyl) -1,3,5-triazine sodium salt, the 2,4-bis - {[4- (3- (2-propyloxy) -2-hydroxy-propyloxy) -2-hydroxy] phenyl} -6- (4-methoxyphenyl) - 1,3,5-triazine, the 2,4-bis - {[4- (2-ethylhexyloxy) -2-hydroxy] phenyl} -6- [4- (2-methoxyethylcarboxyl) phenylamino] -1,3,5-triazine, the 2nd , 4-bis - {[4- (3- (2-propyloxy) -2-hydroxy-propyloxy) - 2-hydroxy] phenyl} -6- [4- (2-ethylcarboxyl) phenylamino] -1,3,5-triazine, the 2,4-bis - {[4- (2- ethyl hexyloxy) -2-hydroxy] phenyl} -6- (1-methyl-pyrrol-2-yl) -1,3,5-triazine, the 2,4-bis - {[4- tris (trimethylsiloxysilylpropyloxy) -2-hydroxy] phenyl} -6- (4-methoxyphenyl) -1,3,5-triazine, the 2,4-bis - {[4- (2 "-methylpropenyloxy) -2-hydroxy] phenyl} -6- (4-methoxyphenyl) -1,3,5-triazine and the 2,4-bis - {[4- (1 ', 1', 1 ', 3', 5 ', 5', 5'-heptamethylsiloxy-2 "-methyl-propyloxy) -2-hydroxy] phenyl} - 6- (4-methoxyphenyl) -1,3,5-triazine.

An advantageous broadband filter in the sense of the present invention is 2,2'-methylenebis (6- (2H-benzotriazol-2-yl) -4- (1,1,3,3-tetramethylbutyl) phenol), which is characterized by the chemical structural formula


and is available under the trade name Tinosorb® M from CIBA-Chemicals GmbH.

Another advantageous broadband filter for the purposes of the present invention is 2- (2H-benzotriazol-2-yl) -4-methyl-6- [2-methyl-3- [1,3,3,3-tetramethyl-1 - [( trimethylsilyl) oxy] disiloxanyl] propyl] phenol (CAS no .: 155633-54-8) with the INCI name Drometrizole Trisiloxane, which is characterized by the chemical structural formula


is marked.

• - 3-Benzylidencampher-Derivate, vorzugsweise 3-(4-Methylbenzyliden)campher, 3-Benzylidencampher;
• - 4-Aminobenzoesäure-Derivate, vorzugsweise 4-(Dimethylamino)-benzoesäure(2-ethylhexyl)ester, 4-(Dimethylamino)benzoesäureamylester;
• - 2,4,6-Trianilino-(p-carbo-2'-ethyl-1'-hexyloxy)-1,3,5-triazin;
• - Ester der Benzalmalonsäure, vorzugsweise 4-Methoxybenzalmalonsäuredi(2-ethylhexyl)- ester;
• - Ester der Zimtsäure, vorzugsweise 4-Methoxyzimtsäure(2-ethylhexyl)ester, 4-Methoxyzimtsäureisopentylester;
• - Derivate des Benzophenons, vorzugsweise 2-Hydroxy-4-methoxybenzophenon, 2- Hydroxy-4-methoxy-4'-methylbenzophenon, 2,2'-Dihydroxy-4-methoxybenzophenon
• - sowie an Polymere gebundene UV-Filter.

The UV-B and / or broadband filters can be oil-soluble or water-soluble. Advantageous oil-soluble UV-B and / or broadband filter substances are e.g. B .:

• - 3-benzylidene camphor derivatives, preferably 3- (4-methylbenzylidene) camphor, 3-benzylidene camphor;
• - 4-aminobenzoic acid derivatives, preferably 4- (dimethylamino) benzoic acid (2-ethylhexyl) ester, 4- (dimethylamino) benzoic acid amyl ester;
• - 2,4,6-trianilino- (p-carbo-2'-ethyl-1'-hexyloxy) -1,3,5-triazine;
• Esters of benzalmalonic acid, preferably 4-methoxybenzalmalonic acid di (2-ethylhexyl) ester;
• - Esters of cinnamic acid, preferably 4-methoxycinnamic acid (2-ethylhexyl) ester, 4-methoxycinnamic acid isopentyl ester;
• - Derivatives of benzophenone, preferably 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'-methylbenzophenone, 2,2'-dihydroxy-4-methoxybenzophenone
• - As well as UV filters bound to polymers.

• - Salze der 2-Phenylbenzimidazol-5-sulfonsäure, wie ihr Natrium-, Kalium- oder ihr Triethanolammonium-Salz, sowie die Sulfonsäure selbst;
• - Sulfonsäure-Derivate des 3-Benzylidencamphers, wie z. B. 4-(2-Oxo-3-bornylidenmethyl)benzolsulfonsäure, 2-Methyl-5-(2-oxo-3-bornylidenmethyl)sulfonsäure und deren Salze.

Advantageous water-soluble UV-B and / or broadband filter substances are e.g. B .:

• - Salts of 2-phenylbenzimidazole-5-sulfonic acid, such as its sodium, potassium or triethanolammonium salt, and the sulfonic acid itself;
• - Sulfonic acid derivatives of 3-benzylidene camphor, such as. B. 4- (2-oxo-3-bornylidene methyl) benzenesulfonic acid, 2-methyl-5- (2-oxo-3-bornylidene methyl) sulfonic acid and salts thereof.

Another light protection filter substance which can advantageously be used according to the invention is ethylhexyl-2-cyano-3,3-diphenylacrylate (octocrylene), which is available from BASF under the name Uvinul® N 539 and is distinguished by the following structure:

It can also be of considerable advantage to be polymer-bound or polymeric To use UV filter substances in preparations according to the present invention, in particular those as described in WO-A-92/20690.

Furthermore, it may be advantageous to add further UV-A and / or Incorporation of UV-B filters in cosmetic or dermatological preparations for example certain salicylic acid derivatives such as 4-isopropylbenzyl salicylate, 2-ethylhexyl salicylate (= Octyl salicylate), homomenthyl salicylate.

The list of UV filters mentioned, used in the sense of the present invention of course, should not be limiting.

The oil phase of the formulations according to the invention is advantageously chosen from the Group of polar oils, for example from the group of lecithins and Fatty acid triglycerides, especially the saturated and / or unsaturated, branched triglycerol esters and / or unbranched alkane carboxylic acids with a chain length of 8 to 24, in particular 12 up to 18 carbon atoms. The fatty acid triglycerides can, for example, be selected advantageously from the group of synthetic, semi-synthetic and natural oils, such as. B. Cocoglyceride, olive oil, sunflower oil, soybean oil, peanut oil, rapeseed oil, almond oil, palm oil, coconut oil, Castor oil, wheat germ oil, grape seed oil, safflower oil, evening primrose oil, macadamia nut oil and the like more.

Further advantageous polar oil components can be used for the purposes of the present invention furthermore selected from the group of the esters from saturated and / or unsaturated, branched and / or unbranched alkane carboxylic acids with a chain length of 3 to 30 C- Atoms and saturated and / or unsaturated, branched and / or unbranched Alcohols with a chain length of 3 to 30 carbon atoms and from the group of esters aromatic carboxylic acids and saturated and / or unsaturated, branched and / or unbranched alcohols with a chain length of 3 to 30 carbon atoms. Such ester oils can then advantageously selected from the group octyl palmitate, octyl cocoate, octyl isostearate, Octyldodeceyl myristate, cetearyl isononanoate, isopropyl myristate, isopropyl palmitate, Isopropyl stearate, isopropyl oleate, n-butyl stearate, n-hexyl laurate, n-decyl oleate, isooctyl stearate, Isononyl stearate, isononyl isononanoate, 2-ethylhexyl palmitate, 2-ethylhexyl laurate, 2-hexyldecyl stearate, 2-octyldodecyl palmitate, stearyl heptanoate, oleyl oleate, olerlerucate, erucyl oleate, erucylerucate, Tridecyl stearate, tridecyl trimellitate, as well as synthetic, semi-synthetic and natural Mixtures of such esters, such as. B. Jojoba oil.

Furthermore, the oil phase can advantageously be selected from the group of dialkyl ethers and Dialkyl carbonates, z. B. dicaprylyl ether (Cetiol OE) and / or Dicaprylyl carbonate, for example that under the trade name Cetiol CC from Cognis available.

It is further preferred that the oil component or components from the group isoeikosan, neopentyl glycol diheptanoate, propylene glycol dicaprylate / dicaprate, caprylic / capric / diglyceryl succinate, butylene glycol dicaprylate / dicaprate, C _12-13 alkyl lactate, di-C 12- aryl triethyl, di-C _12-13 aryl Hexacaprylate / hexacaprate, propylene glycol monoisostearate, tricaprylin, dimethyl isosorbide. It is particularly advantageous if the oil phase of the formulations according to the invention has a content of C _12-15 alkyl benzoate or consists entirely of this.

Advantageous oil components are also e.g. B. butyl octyl salicylate (for example, under Trade name Hallbrite BHB available from CP Hall), hexadecyl benzoate and Butyl octyl benzoate and mixtures thereof (Hallstar AB) and / or diethylhexyl naphthalate (Hallbrite TQ).

Any mixtures of such oil and wax components are also advantageous in the sense to use the present invention.

Furthermore, the oil phase may also advantageously contain non-polar oils, for example those that are selected from the group of branched and unbranched Hydrocarbons and waxes, especially mineral oil, petroleum jelly (petrolatum), paraffin oil, Squalane and squalene, polyolefins, hydrogenated polyisobutenes and isohexadecane. Under Polydecenes are the preferred substances for polyolefins.

Particularly advantageous preparations are also obtained when added or Active ingredients antioxidants are used. According to the Preparations advantageously one or more antioxidants. As cheap, but still optional Antioxidants to be used can all be for cosmetic and / or dermatological Applications suitable or customary antioxidants can be used.

It is also advantageous to add antioxidants to the preparations according to the invention. The antioxidants are advantageously selected from the group consisting of amino acids (e.g. glycine, histidine, tyrosine, tryptophan) and their derivatives, imidazoles (e.g. urocanic acid) and their derivatives, peptides such as D, L-carnosine, D- Carnosine, L-carnosine and their derivatives (e.g. anserine), carotenoids, carotenes (e.g. α-carotene, β-carotene, lycopene) and their derivatives, chlorogenic acid and its derivatives, lipoic acid and its derivatives (e.g. As dihydrolipoic acid), aurothioglucose, propylthiouracil and other thiols (e.g. thioredoxin, glutathione, cysteine, cystine, cystamine and their glycosyl, N-acetyl, methyl, ethyl, propyl, amyl, butyl and Lauryl, palmitoyl, oleyl, γ-linoleyl, cholesteryl and glyceryl esters) and their salts, dilauryl thiodipropionate, distearyl thiodipropionate, thiodipropionic acid and their derivatives (esters, ethers, peptides, lipids, nucleotides, nucleosides and salts) and sulfoximine compounds (e.g. B. Buthioninsulfoximine, Homocysteinsulfoximin, Buthioninsulf one, penta-, hexa-, heptathioninsulfoximine) in very low tolerable doses (e.g. B. pmol to µmol / kg), furthermore (metal) chelators (e.g. α-hydroxy fatty acids, palmitic acid, phytic acid, lactoferrin), α-hydroxy acids (e.g. citric acid, lactic acid, malic acid), humic acid, bile acid, Bile extracts, bilirubin, biliverdin, EDTA, EGTA and their derivatives, unsaturated fatty acids and their derivatives (e.g. γ-linolenic acid, linoleic acid, oleic acid), folic acid and their derivatives, ubiquinone and ubiquinol and their derivatives, vitamin C and derivatives (e.g. B. Ascorbyl palmitate, Mg ascorbyl phosphate, ascorbyl acetate), tocopherols and derivatives (e.g. vitamin E acetate), vitamin A and derivatives (vitamin A palmitate) and coniferyl benzoate of benzoin, rutinic acid and its derivatives, α- (z. B. ZnO, ZnSO ₄₎ rutin, ferulic acid, Furfurylidenglucitol, carnosine, butylhydroxytoluene, butylhydroxyanisole, Nordihydroguajakharzsäure, nordihydroguaiaretic acid, trihydroxybutyrophenone, uric acid and derivatives thereof, mannose and derivatives thereof, zinc and derivatives thereof S elen and its derivatives (e.g. B. selenomethionine), stilbenes and their derivatives (for example stilbene oxide, trans-stilbene oxide) and the derivatives suitable according to the invention (salts, esters, ethers, sugars, nucleotides, nucleosides, peptides and lipids) of these active substances.

Oil-soluble can be particularly advantageous in the sense of the present invention Antioxidants are used.

An astonishing property of the present invention is that according to the invention Preparations very good vehicles for cosmetic or dermatological active ingredients in the Skin are preferred antioxidants which act on the skin can protect against oxidative stress. Preferred antioxidants are vitamin E. and its derivatives and vitamin A and its derivatives.

The amount of antioxidants (one or more compounds) in the preparations is preferably 0.001 to 30% by weight, particularly preferably 0.05-20% by weight, in particular 1-10 wt .-%, based on the total weight of the preparation.

If vitamin E and / or its derivatives are the antioxidant (s) advantageous, their respective concentrations from the range of 0.001-10% by weight, based on the total weight of the formulation.

If vitamin A, or vitamin A derivatives, or carotenes or their derivatives, the or the antioxidants are advantageous, their respective concentrations from the Range of 0.001-10% by weight based on the total weight of the formulation choose.

Powders are composed of one or more powder bases, more or less finely divided, powdered preparations, which, their application accordingly, one or more active ingredients, preservatives, perfume oils, dyes, etc. can be added.

The FDA's OTC Miscellaneous External Panel has the following definition for powder stated: "A homogeneous dispersion of finely divided, relatively dry fine particles Materials consisting of one or more substances "(FDC Reports [Pink Sheet] 41, No. 33, T & G-4 [Aug. 13, 1979]).

The composition of a powder largely depends on the tasks it is supposed to has fulfilled. Powder can also be used as a diluent for medication, e.g. B. antibiotics, Sulfonamides, etc. Liquid powders are mostly made of talc, zinc oxide and / or Titanium dioxide, glycerin and water existing viscous preparations (shake mixes). Compact powders are briquetted by high pressure or by adding calcium sulfate (gypsum) sintered powder bases.

In addition, powders are also made available and used in aerosol form, after having managed to develop valves that could block the possibility of To a large extent exclude valve gears.

The sedimentation of the incorporated powder particles, which is always to be feared, can also occur can be prevented if suitable suspending agents or Suspending aids incorporated, for example alkali metal, ammonium or amine salts Dialkyl sulfosuccinate with alkyl groups of 4-12 C atoms, e.g. B. sodium dioctyl sulfosuccinate (typically about 0.002-0.015% by weight), or an alkylbenzenesulfonic acid with alkyl groups of 8-14 carbon atoms, e.g. B. sodium dodecylbenzenesulfonate.

The following examples are intended to illustrate the present invention without restricting it. The numerical values in the examples mean percentages by weight, based on the total weight of the respective preparations. In the examples, "aminobenzophenone" is to be understood as meaning the hexyl 2- (4 '- (diethylamino) -2'-hydoxybenzoyl) benzoate. Examples 1. O / W emulsions






3. W / O emulsions



4. Solid stabilized emulsions

Claims (14)

1. Cosmetic and / or dermatological preparation for protection against UV radiation with bis-resorcinyltriazine derivatives characterized by the following structure:


where R ¹ , R ² and R ³ are selected independently of one another from the group of branched and unbranched alkyl groups having 1 to 10 carbon atoms or represent a single hydrogen atom,
inorganic micropigments and
at least one siloxane elastomer selected from the group of siloxane elastomers obtainable either by reaction of vinyl-terminated polymethylsiloxane and methylhydrodimenthylsiloxane or by reaction of hydroxyl-terminated dimethylpolysiloxane and trimethylsiloxy-terminated methylpolysiloxane, in the form of spherical powders or in the form of gels. 2. Preparation according to claim 1, characterized in that siloxane elastomers selected from the groups of siloxane elastomers, (a) contain the units R ₂ SiO and RSiO _1.5 and / or R3SiO _0.5 and / or SiO ₂ , the individual radicals R each independently represent hydrogen, alkyl such as methyl, ethyl, propyl or aryl such as phenyl or tolyl, alkenyl such as vinyl and the weight ratio of the units R ₂ SiO to RSiO _1.5 chosen in the range from 1: 1 to 30: 1 becomes;
(b) which are insoluble and swellable in silicone oil, which can be obtained by the addition reaction of an organopolysiloxane (1) which contains silicon-bonded hydrogen with an organopolysiloxane (2) which contains unsaturated aliphatic groups, the proportions used being chosen so that the amount of hydrogen of the organopolysiloxane (1) or the unsaturated aliphatic groups of the organopolysiloxane (2) is in the range of 1 to 20 mol% when the organopolysiloxane is not cyclic and in the range of 1 to 50 mol% when the organopolysiloxane is cyclic. 3. Preparation according to at least one of the preceding claims characterized in that the organopolysiloxane elastomer in combination with oils Hydrocarbons of animal and / or vegetable origin, synthetic oils, synthetic esters, synthetic ethers or mixtures thereof is used. 4. Preparation according to at least one of the preceding claims characterized in that the organopolysiloxane elastomer in combination with unbranched at room temperature liquid or pasty silicone oils or cyclic silicone oils or mixtures thereof are used. 5. Preparation according to at least one of the preceding claims characterized in that the organopolysiloxane elastomer is in the form of a gel Organopolysiloxane elastomer and a lipid phase is used, the content of Organopolysiloxane elastomer in the gel is 3 to 80% by weight. 6. Preparation according to at least one of the preceding claims characterized in that the organopolysiloxane elastomer in combination with a Lipid phase is used, the content of the organopolysiloxane elastomer in the Preparation is 0.3 to 60 wt .-%. 7. Preparation according to at least one of the preceding claims characterized in that as an inorganic micropigment metal oxides with a medium Particle size from 10 to 60 nm can be used. 8. Preparation according to at least one of the preceding claims characterized in that as inorganic micropigments oxides of titanium, iron, zinc, Zirconium or cerium can be used. 9. Preparation according to at least one of the preceding claims characterized in that coated as inorganic micropigments metal oxides be used. 10. Preparation according to at least one of the preceding claims characterized in that the inorganic micropigments in a proportion of 0.5 to 30 % By weight are present. 11. Preparation according to at least one of the preceding claims, characterized characterized in that the bis-resorcinyltriazine derivative is the 2,4-bis - {[4- (2-ethylhexyloxy) -2- hydroxy] phenyl] -6- (4-methoxyphenyl) -1,3,5-triazine with the INCI name Aniso Triazine. 12. Preparation according to at least one of the preceding claims, characterized characterized in that the content of one or more bis-resorcinyltriazine derivatives the range 0.1 to 20 wt .-%, advantageously 0.1 to 15 wt .-%, very particularly preferably 0.1 to 10 wt .-% is selected. 13. Preparation according to at least one of the preceding claims, characterized characterized in that they selected at least one additional UV filter substance from the Group triazines, hydroxyaminobenzophenones, the UV liquid that is liquid at room temperature Filters, sulfonated, water-soluble UV filters, oil-soluble UV broadband filters and organic and / or inorganic pigments, which are preferably treated on the surface. 14. Use of a preparation according to at least one of the preceding claims to protect the skin or hair from UV light, damage caused by UV light and signs of aging caused by UV light.